A simultaneous knockout knockin genome editing strategy in HSPCs potently inhibits CCR5- and CXCR4-tropic HIV-1 infection
Cell Stem Cell · 2024-04 · 31 (4) · 499-518.e6
DOI: 10.1016/j.stem.2024.03.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Stem Cell, 2024-04. Verfasst von Amanda M Dudek und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA; Institute for Stem Cell Biology & Regenerative Medicine, S…. Hauptthemen laut MEDLINE: Gene Editing, HIV Infections, HIV-1. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Allogeneic hematopoietic stem and progenitor cell transplant (HSCT) of CCR5 null (CCR5Δ32) cells can be curative for HIV-1-infected patients. However, because allogeneic HSCT poses significant risk, CCR5Δ32 matched bone marrow donors are rare, and CCR5Δ32 transplant does not confer resistance to the CXCR4-tropic virus, it is not a viable option for most patients. We describe a targeted Cas9/AAV6-based genome editing strategy for autologous HSCT resulting in both CCR5- and CXCR4-tropic HIV-1 resistance. Edited human hematopoietic stem and progenitor cells (HSPCs) maintain multi-lineage repopulation capacity in vivo, and edited primary human T cells potently inhibit infection by both CCR5-tropic and CXCR4-tropic HIV-1. Modification rates facilitated complete loss of CCR5-tropic replication and up to a 2,000-fold decrease in CXCR4-tropic replication without CXCR4 locus disruption. This multi-factor editing strategy in HSPCs could provide a broad approach for autologous HSCT as a functional cure for both CCR5-tropic and CXCR4-tropic HIV-1 infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA; Institute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
- Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark; Aarhus Institute of Advanced Studies (AIAS), Aarhus Universi…
- Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA; Institute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA. Electr…
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- Blavatnik Family Foundation
- Danmarks Frie Forskningsfond
Zitieren
APA
Dudek, A. M., Feist, W. N., Sasu, E. J., Luna, S. E., Ben-Efraim, K., Bak, R. O., Cepika, A. M., & Porteus, M. H. (2024). A simultaneous knockout knockin genome editing strategy in HSPCs potently inhibits CCR5- and CXCR4-tropic HIV-1 infection. Cell Stem Cell, 31(4), 499-518.e6. https://doi.org/10.1016/j.stem.2024.03.002
Vancouver
Dudek AM, Feist WN, Sasu EJ, Luna SE, Ben-Efraim K, Bak RO, et al. A simultaneous knockout knockin genome editing strategy in HSPCs potently inhibits CCR5- and CXCR4-tropic HIV-1 infection. Cell Stem Cell. 2024;31(4):499-518.e6. doi:10.1016/j.stem.2024.03.002
BibTeX
@article{Dudek2024,
author = {Dudek, Amanda M and Feist, William N and Sasu, Elena J and Luna, Sofia E and Ben-Efraim, Kaya and Bak, Rasmus O and Cepika, Alma-Martina and Porteus, Matthew H},
title = {A simultaneous knockout knockin genome editing strategy in HSPCs potently inhibits CCR5- and CXCR4-tropic HIV-1 infection},
journal = {Cell Stem Cell},
year = {2024},
volume = {31},
number = {4},
pages = {499--518.e6},
doi = {10.1016/j.stem.2024.03.002}
}
EUVIMED